Driehaus Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Driehaus Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$321M	Buy	959,048 +9,823	+1%	+$3.11M	1.86%	3
2026 Q1	$306M	Buy	949,225 +16,164	+2%	+$5M	2.25%	2
2025 Q4	$275M	Buy	933,061 +432,510	+86%	+$80.5M	1.87%	3
2025 Q3	$26.5M	Sell	500,551 -30,437	-6%	-$1.48M	0.19%	175
2025 Q2	$22.3M	Buy	530,988 +49,390	+10%	+$1.88M	0.18%	165
2025 Q1	$18.2M	Buy	481,598 +316,686	+192%	+$19.8M	0.18%	171
2024 Q4	$12.7M	Sell	164,912 -1,144	-0.7%	-$82.8K	0.1%	220
2024 Q3	$9.55M	Sell	166,056 -98,632	-37%	-$5.33M	0.08%	235
2024 Q2	$10.9M	Sell	264,688 -1,808	-0.7%	-$85.4K	0.11%	208
2024 Q1	$16.3M	Buy	+266,496	New	+$12M	0.16%	186

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Driehaus Capital Management's PRAX Position: Q2 2026 in Review

Driehaus Capital Management increased its Praxis Precision Medicines (PRAX) stake by 1% in Q2 2026, buying an estimated $3.11M and bringing the position to 959,048 shares worth $321M. The position accounts for 1.86% of the portfolio, ranked #3.

Driehaus Capital Management first reported a position in PRAX in Q1 2024 and has held it in 10 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Driehaus Capital Management held 959,048 shares of Praxis Precision Medicines worth $321M as of Q2 2026.
Driehaus Capital Management bought 9,823 Praxis Precision Medicines shares in Q2 2026, an estimated $3.11M.
Praxis Precision Medicines made up 1.86% of Driehaus Capital Management's portfolio in Q2 2026, its #3 holding.
Driehaus Capital Management first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 10 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.